(Q83259870)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21254451%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

review article

1 reference

title

Annual banned-substance review: analytical approaches in human sports drug testing (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21254451%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Mario Thevis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21254451%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Tiia Kuuranne

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21254451%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Hans Geyer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21254451%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Wilhelm Schänzer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21254451%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

14 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21254451%20AND%20SRC:MED&resulttype=core&format=json

Drug Testing and Analysis

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21254451%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21254451%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21254451%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

1-14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21254451%20AND%20SRC:MED&resulttype=core&format=json

Annual banned-substance review: analytical approaches in human sports drug testing

20 January 2020

cites work

1 reference

7 January 2021

Mass spectrometry-based characterization of new drugs and methods of performance manipulation in doping control analysis

1 reference

7 January 2021

Detecting the administration of endogenous anabolic androgenic steroids

1 reference

7 January 2021

Biochemical and physiological aspects of endogenous androgens

1 reference

7 January 2021

Nandrolone: a multi-faceted doping agent

1 reference

7 January 2021

1 reference

7 January 2021

1 reference

7 January 2021

Synthetic anabolic agents: steroids and nonsteroidal selective androgen receptor modulators

1 reference

7 January 2021

Comprehensive two-dimensional gas chromatography improves separation and identification of anabolic agents in doping control

1 reference

7 January 2021

Evaluation of World Anti-Doping Agency criteria for anabolic agent analysis by using comprehensive two-dimensional gas chromatography-mass spectrometry

1 reference

7 January 2021

Dehydroepiandrosterone to enhance physical performance: myth and reality

1 reference

7 January 2021

Endogenous steroid profiling in the athlete biological passport

1 reference

7 January 2021

Reference ranges for urinary concentrations and ratios of endogenous steroids, which can be used as markers for steroid misuse, in a Caucasian population of athletes

1 reference

7 January 2021

Degradation of urine samples and its influence on the ¹³C/¹²C ratios of excreted steroids

1 reference

7 January 2021

Determination of 13C/12C ratios of urinary epitestosterone and its main metabolites 5alpha- and 5beta-androstane-3alpha, 17alpha-diol

1 reference

7 January 2021

Development of criteria for the detection of adrenosterone administration by gas chromatography-mass spectrometry and gas chromatography-combustion-isotope ratio mass spectrometry for doping control

1 reference

7 January 2021

Preventive doping control screening analysis of prohibited substances in human urine using rapid-resolution liquid chromatography/high-resolution time-of-flight mass spectrometry

1 reference

7 January 2021

Detection of mono-hydroxylated metabolites of stanozolol by HPLC-ESI (+) MS/MS in Indian sports persons

1 reference

7 January 2021

Application of FAIMS to anabolic androgenic steroids in sport drug testing

1 reference

7 January 2021

Determination of anabolic steroids in human urine by automated in-tube solid-phase microextraction coupled with liquid chromatography-mass spectrometry

1 reference

7 January 2021

Determination of nandrolone metabolites in human urine: comparison between liquid chromatography/tandem mass spectrometry and gas chromatography/mass spectrometry

1 reference

7 January 2021

Analysis of anabolic steroids in human hair using LC-MS/MS.

1 reference

7 January 2021

uPA+/+-SCID mouse with humanized liver as a model for in vivo metabolism of exogenous steroids: methandienone as a case study.

1 reference

7 January 2021

Steroid metabolism in chimeric mice with humanized liver

1 reference

7 January 2021

The uPA(+/+)-SCID mouse with humanized liver as a model for in vivo metabolism of 4-androstene-3,17-dione

1 reference

7 January 2021

Detection and characterization of a new metabolite of 17alpha-methyltestosterone

1 reference

7 January 2021

Detection and structural investigation of metabolites of stanozolol in human urine by liquid chromatography tandem mass spectrometry

1 reference

7 January 2021

Combination of liquid-chromatography tandem mass spectrometry in different scan modes with human and chimeric mouse urine for the study of steroid metabolism

1 reference

7 January 2021

Comparative in vitro metabolism of the 'designer' steroid estra-4,9-diene-3,17-dione between the equine, canine and human: identification of target metabolites for use in sports doping control

1 reference

7 January 2021

CYP21-catalyzed production of the long-term urinary metandienone metabolite 17beta-hydroxymethyl-17 alpha-methyl-18-norandrosta-1,4,13-trien-3-one: a contribution to the fight against doping.

1 reference

7 January 2021

Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes

1 reference

7 January 2021

Speeding up the process urine sample pre-treatment: some perspectives on the use of microwave assisted extraction in the anti-doping field

1 reference

7 January 2021

Toward the use of a molecularly imprinted polymer in doping analysis: selective preconcentration and analysis of testosterone and epitestosterone in human urine.

1 reference

7 January 2021

UDP-glucuronosyltransferases (UGTs) 2B7 and UGT2B17 display converse specificity in testosterone and epitestosterone glucuronidation, whereas UGT2A1 conjugates both androgens similarly

1 reference

7 January 2021

Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids.

1 reference

7 January 2021

Pilot study of serum inhibin B as a potential marker of testosterone doping in weight lifting men.

1 reference

7 January 2021

Ethylglucuronide as a potential marker for alcohol-induced elevation of urinary testosterone/epitestosterone ratios

1 reference

7 January 2021

Application of mass spectrometry-based proteomics techniques for the detection of protein doping in sports

1 reference

7 January 2021

Erythropoietin and analogs

1 reference

7 January 2021

Procedures for monitoring recombinant erythropoietin and analogs in doping.

1 reference

7 January 2021

Purification of erythropoietin from human plasma samples using an immunoaffinity well plate.

1 reference

7 January 2021

SARCOSYL-PAGE: a new method for the detection of MIRCERA- and EPO-doping in blood

1 reference

7 January 2021

A rapid and simple assay to determine pegylated erythropoietin in human serum.

1 reference

7 January 2021

Effects of high intensity exercise on isoelectric profiles and SDS-PAGE mobility of erythropoietin

1 reference

7 January 2021

IEF pattern classification-derived criteria for the identification of epoetin-delta in urine.

1 reference

7 January 2021

Insulin-like growth factor I and insulin and their abuse in sport.

1 reference

7 January 2021

Drugs of abuse and the adolescent athlete

1 reference

7 January 2021

1 reference

7 January 2021

Detection of surreptitious administration of analog insulin to an 8-week-old infant

1 reference

7 January 2021

Detecting growth hormone abuse in athletes

1 reference

7 January 2021

1 reference

7 January 2021

Detecting growth hormone abuse in athletes.

1 reference

7 January 2021

Pharmacology. Growth hormone test finally nabs first doper

1 reference

7 January 2021

Is human growth hormone an ergogenic aid?

1 reference

7 January 2021

Growth hormone administration: is it safe and effective for athletic performance

1 reference

7 January 2021

The effects of growth hormone on body composition and physical performance in recreational athletes: a randomized trial.

1 reference

7 January 2021

The GH-2004 project: the response of IGF1 and type III pro-collagen to the administration of exogenous GH in non-Caucasian amateur athletes.

1 reference

7 January 2021

Serum insulin-like growth factor-I and pro-collagen type III N-terminal peptide in adolescent elite athletes: implications for the detection of growth hormone abuse in sport.

1 reference

7 January 2021

The use of growth hormone (GH)-dependent markers in the detection of GH abuse in sport: Physiological intra-individual variation of IGF-I, type 3 pro-collagen (P-III-P) and the GH-2000 detection score.

1 reference

7 January 2021

Enrichment and immunoprecipitation of 22 kDa human growth hormone spiked into human urine

1 reference

7 January 2021

Nanoparticle technology: amplifying the effective sensitivity of biomarker detection to create a urine test for hGH.

1 reference

7 January 2021

Detection of growth hormone doping by gene expression profiling of peripheral blood.

1 reference

7 January 2021

Mass spectrometry-based analysis of IGF-1 and hGH.

1 reference

7 January 2021

Detection of His-tagged Long-R3-IGF-I in a black market product

1 reference

7 January 2021

Comprehensive plasma-screening for known and unknown substances in doping controls

1 reference

7 January 2021

Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry

1 reference

7 January 2021

Growth factors, muscle function, and doping.

1 reference

7 January 2021

Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes

1 reference

7 January 2021

beta-Adrenergic stimulation

1 reference

7 January 2021

Terbutaline sulfoconjugate: characterization and urinary excretion monitored by LC/ESI-MS/MS.

1 reference

7 January 2021

Rapid screening of beta-adrenergic agents and related compounds in human urine for anti-doping purpose using capillary electrophoresis with dynamic coating

1 reference

7 January 2021

Adsorption of beta-adrenergic agonists used in sport doping on metal nanoparticles: a detection study based on surface-enhanced Raman scattering.

1 reference

7 January 2021

Mass spectrometric characterization of tamoxifene metabolites in human urine utilizing different scan parameters on liquid chromatography/tandem mass spectrometry

1 reference

7 January 2021

The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis

1 reference

7 January 2021

Masking and manipulation

1 reference

7 January 2021

A rapid screening LC-MS/MS method based on conventional HPLC pumps for the analysis of low molecular weight xenobiotics: application to doping control analysis

1 reference

7 January 2021

Generic sample preparation combined with high-resolution liquid chromatography-time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories.

1 reference

7 January 2021

Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry. II: Confirmatory analysis

1 reference

7 January 2021

Screening for hydroxyethyl starch (HES) doping in sport

1 reference

7 January 2021

Stimulants and doping in sport

1 reference

7 January 2021

[Doping in disabled sports. Doping control activities at the Paralympic Games 1984-2008 and in Germany 1992-2008]

1 reference

7 January 2021

The fight against doping: back on track with blood

1 reference

7 January 2021

Analysis of stimulants in oral fluid and urine by gas chromatography-mass spectrometry II: pseudophedrine

1 reference

7 January 2021

Simultaneous analysis of fourteen tertiary amine stimulants in human urine for doping control purposes by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry

1 reference

7 January 2021

Detection in urine of 4-methyl-2-hexaneamine, a doping agent

1 reference

7 January 2021

Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry

1 reference

7 January 2021

Confirming urinary excretion of mephentermine and phentermine following the ingestion of oxethazaine by gas chromatography-mass spectrometry analysis

1 reference

7 January 2021

Comparison of the analysis of beta-blockers by different techniques

1 reference

7 January 2021

Glucocorticoids: a doping agent?

1 reference

7 January 2021

Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products

1 reference

7 January 2021

Chemical analysis of synthetic cannabinoids as designer drugs in herbal products

1 reference

7 January 2021

Detection of JWH-018 metabolites in smoking mixture post-administration urine

1 reference

7 January 2021

Temporal indication of cannabis use by means of THC glucuronide determination

1 reference

7 January 2021

Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes

1 reference

7 January 2021

Direct quantification of 11-nor-Delta(9)-tetrahydrocannabinol-9-carboxylic acid in urine by liquid chromatography/tandem mass spectrometry in relation to doping control analysis

1 reference

7 January 2021

Blood transfusion in sports

1 reference

7 January 2021

The athlete's biological passport and indirect markers of blood doping

1 reference

7 January 2021

Preanalytical variability: the dark side of the moon in blood doping screening

1 reference

7 January 2021

ORIGINAL ARTICLE: Are 10 min of seating enough to guarantee stable haemoglobin and haematocrit readings for the athlete’s biological passport?

1 reference

7 January 2021

Reticulocyte profile in top-level alpine skiers during four consecutive competitive seasons

1 reference

7 January 2021

Diurnal and exercise-related variability of haemoglobin and reticulocytes in athletes

1 reference

7 January 2021

Stability of hemoglobin mass during a 6-day UCI ProTour cycling race

1 reference

7 January 2021

Assessment of total haemoglobin mass: can it detect erythropoietin-induced blood manipulations?

1 reference

7 January 2021

Analysis of hemoglobin-based oxygen carriers by CE-UV/Vis and CE-ESI-TOF/MS

1 reference

7 January 2021

A fast screening method for the detection of the abuse of hemoglobin-based oxygen carriers (HBOCs) in doping control

1 reference

7 January 2021

How close are we to gene doping?

1 reference

7 January 2021

Ethics. Gene doping and sport

1 reference

7 January 2021

Gene doping: the hype and the harm

1 reference

7 January 2021

The human genome and sport, including epigenetics, gene doping, and athleticogenomics

1 reference

7 January 2021

1 reference

7 January 2021

RNA interference: from basic research to therapeutic applications

1 reference

7 January 2021

Mass spectrometric detection of siRNA in plasma samples for doping control purposes

1 reference

7 January 2021

Quantification of urinary AICAR concentrations as a matter of doping controls

1 reference

7 January 2021

Characterization of two major urinary metabolites of the PPARδ-agonist GW1516 and implementation of the drug in routine doping controls

1 reference

7 January 2021

Emerging drugs: mechanism of action, mass spectrometry and doping control analysis

1 reference

7 January 2021

Gene doping detection: evaluation of approach for direct detection of gene transfer using erythropoietin as a model system

1 reference

7 January 2021

Affinity sensing for transgenes detection in antidoping control

1 reference

7 January 2021

Identifiers

DOI

10.1002/DTA.245

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21254451%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference